Sol-Gel Technologies (SLGL) Total Liabilities (2016 - 2026)
Sol-Gel Technologies (SLGL) reported Total Liabilities of $7.1 million for Q1 2026, up 3.67% year-over-year from $6.9 million in Q1 2025, and up 0.53% quarter-over-quarter from $7.1 million in Q4 2025.
Sol-Gel Technologies (SLGL) Total Liabilities (2016 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 11 years of Total Liabilities data on file, last reported at $7.1 million in Q1 2026.
- Total Liabilities for Q1 2026 came in at $7.1 million, up 3.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.1 million (up 3.67% YoY), and the FY2025 annual result was $7.1 million, up 1.57% from the prior year.
- Total Liabilities rose to $7.1 million in Q1 2026 per SLGL's latest filing, from $7.1 million in the prior quarter.
- Over five years, Total Liabilities peaked at $8.6 million in Q3 2025 and troughed at $3.8 million in Q3 2022.
- A 5-year average of $6.5 million and a median of $6.9 million in 2025 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2022 and 2023: Total Liabilities plunged 67.52% in 2022, then jumped 76.61% in 2023.
- A 5-year view of Total Liabilities shows it stood at $4.4 million in 2022, then jumped by 50.46% to $6.6 million in 2023, then gained by 5.31% to $7.0 million in 2024, then gained by 1.57% to $7.1 million in 2025, then climbed by 0.53% to $7.1 million in 2026.
- Business Quant data shows SLGL's Total Liabilities at $7.1 million in Q1 2026, $7.1 million in Q4 2025, and $8.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Sol-Gel Technologies | 207.80 Mn | 197.67 Mn | - | 7.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.14 Mn |
| Dec 31, 2025 | 7.11 Mn |
| Sep 30, 2025 | 8.56 Mn |
| Jun 30, 2025 | 7.43 Mn |
| Mar 31, 2025 | 6.89 Mn |
| Dec 31, 2024 | 7.00 Mn |
| Sep 30, 2024 | 8.28 Mn |
| Jun 30, 2024 | 7.10 Mn |
| Mar 31, 2024 | 7.26 Mn |
| Dec 31, 2023 | 6.64 Mn |
| Sep 30, 2023 | 6.74 Mn |
| Jun 30, 2023 | 6.81 Mn |
| Mar 31, 2023 | 4.98 Mn |
| Dec 31, 2022 | 4.42 Mn |
| Sep 30, 2022 | 3.81 Mn |
| Jun 30, 2022 | 4.63 Mn |
| Mar 31, 2022 | 5.93 Mn |
| Dec 31, 2021 | 13.60 Mn |
| Sep 30, 2021 | 11.38 Mn |
| Jun 30, 2021 | 7.16 Mn |